EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Clinical value of therapeutic drug monitoring for levetiracetam in pediatric patients with epilepsy

Yoshiaki Yamamoto, Akiko Ohta, Naotaka Usui, Katsumi Imai, Yoshiyuki Kagawa, Yukitoshi Takahashi

Brain and Development · 2023-05 · 45 (5) · 285-292

DOI: 10.1016/j.braindev.2023.01.007 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Brain and Development, 2023-05. Verfasst von Yoshiaki Yamamoto und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Research, NHO, National Epilepsy Center, Shizuoka Institute of Epilepsy and Neurological Disorders, 886 Urushiyama, Shizuoka 4…. Hauptthemen laut MEDLINE: Epilepsy, Piracetam. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Japan Society for the Promotion of Science, Ministry of Education, Culture, Sports, Science and Technology, Japan Research Foundation for Clinical Pharmacology.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

EpilepsyPiracetamChild, PreschoolInfantAdolescentHumansChildInfant, NewbornLevetiracetamAnticonvulsantsDrug MonitoringRetrospective Studies

Stichwörter der Autor:innen

Chronic kidney diseasesDrug interactionsLevetiracetamPediatricsTherapeutic drug monitoring

Substanzen

LevetiracetamAnticonvulsantsPiracetam

Autor:innen und Institutionen

  • Department of Clinical Research, NHO, National Epilepsy Center, Shizuoka Institute of Epilepsy and Neurological Disorders, 886 Urushiyama, Shizuoka 420-8688, Japan; Department of Clinical Pharmaceutics, Graduate School…
  • Department of Clinical Research, NHO, National Epilepsy Center, Shizuoka Institute of Epilepsy and Neurological Disorders, 886 Urushiyama, Shizuoka 420-8688, Japan.
  • Department of Clinical Pharmaceutics, Graduate School of Pharmaceutical Sciences, University of Shizuoka, 52-1 Yada, Shizuoka 422-8526, Japan; Laboratory of Clinical Pharmacokinetics and Drug Safety, Shizuoka General Ho…

Förderung

  • Japan Society for the Promotion of Science
  • Ministry of Education, Culture, Sports, Science and Technology
  • Japan Research Foundation for Clinical Pharmacology

Zitieren

APA

Yamamoto, Y., Ohta, A., Usui, N., Imai, K., Kagawa, Y., & Takahashi, Y. (2023). Clinical value of therapeutic drug monitoring for levetiracetam in pediatric patients with epilepsy. Brain and Development, 45(5), 285-292. https://doi.org/10.1016/j.braindev.2023.01.007

Vancouver

Yamamoto Y, Ohta A, Usui N, Imai K, Kagawa Y, Takahashi Y. Clinical value of therapeutic drug monitoring for levetiracetam in pediatric patients with epilepsy. Brain and Development. 2023;45(5):285-292. doi:10.1016/j.braindev.2023.01.007

BibTeX
@article{Yamamoto2023,
  author = {Yamamoto, Yoshiaki and Ohta, Akiko and Usui, Naotaka and Imai, Katsumi and Kagawa, Yoshiyuki and Takahashi, Yukitoshi},
  title = {Clinical value of therapeutic drug monitoring for levetiracetam in pediatric patients with epilepsy},
  journal = {Brain and Development},
  year = {2023},
  volume = {45},
  number = {5},
  pages = {285--292},
  doi = {10.1016/j.braindev.2023.01.007}
}
Infokarte | EUVIMED

Artikeldaten derzeit nicht verfügbar.

Recherche